[1]
“Glycemic Control of Non-Hodgkin Lymphoma (NHL) Non-Diabetes Mellitus (DM) Patient in the First CHOP Chemotherapy”, MLU, vol. 21, no. 1, pp. 393–400, Jan. 2021, doi: 10.37506/mlu.v21i1.2341.